Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes
NCT06057246 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2023-10-11
Summary
Postprandial glycemia (PPG) is a relevant determinant of glucose control in people with type 2 diabetes (T2D). Epidemiological and pathophysiological studies indicate that PPG is a better risk predictor for cardiovascular disease and all-cause mortality than fasting plasma glucose. Therefore, both fasting and postprandial glycemia should be targeted to achieve optimal glycemic control and, thus, prevent or reduce the risk of diabetes complications.
Post-prandial glucose response (PGR) cannot be predicted based solely on the meals' carbohydrate content. Recent research using continuous glucose monitoring (CGM) systems has identified different patterns of PGR to a standard meal among both healthy people and individuals with type 1 diabetes. Different contributors to the PGR have emerged, including genotype, hormonal and metabolic factors, phenotype, gut microbiota composition, background diet, sleep habits, physical activity levels.
The present project aims at exploring the PGR in a real-life setting in a cohort of people with T2D, and identifying person-specific factors associated with different postprandial glucose patterns.
To this purpose, 144 individuals with T2D on treatment with diet alone or diet plus metformin will be characterized for their anthropometric, metabolic, and gut-microbiome features and will undergo a one-week observational period through CGM system, while properly recording their food intake, physical activity, and sleep habits. A mixed-nutrient standardized meal will be consumed at home in two occasions by each participant to investigate the intra-individual variability of the PGR. Moreover, in a subgroup of participants (n=60), divided according to anthropometric and metabolic features, hormonal and metabolic response to the standardized meal will be evaluated at the hospital, to explore the contribution of different T2D phenotypes to the PGR.
A further step will be developing a prediction algorithm of PGR based on the intra- and inter-individual factors shown to influence postprandial glucose, able to further optimize the management of T2D with precision therapeutic strategies.
Conditions
Interventions
- OTHER
-
Test meal with postprandial samples
The mixed-nutrient test meal consists of a sandwich made with bread, spread cheese, air-cured beef, and one apple. Nutritional composition of the meal will be: total energy (TE) content 532 kcal, carbohydrates 68,4 g (49.3% TE), total fat 17.1 g (29.5% TE), protein 27.8 g (21.4% TE), and fibre 6 g. Before and over 4 hours after the meal, venous blood samples will be taken for biochemical evaluations at the time points -15'; 0'; 15'; 30'; 60'; 120'; 180'; 240'.
Sponsors & Collaborators
-
Federico II University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-15
- Primary Completion
- 2024-09-30
- Completion
- 2025-05-31
Countries
- Italy
Study Locations
More Related Trials
-
Relative Contribution of Brain Insulin Action for Postprandial Metabolism
NCT06295640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
NCT02592421 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
NCT02792400 ·Status: COMPLETED ·Phase: NA
-
Study of Postprandial Incretin Response in Women With Gestational Diabetes
NCT01274052 ·Status: COMPLETED
-
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
NCT06424106 ·Status: RECRUITING ·Phase: NA
-
Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes
NCT01977833 ·Status: UNKNOWN ·Phase: NA
-
The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes
NCT06426823 ·Status: COMPLETED ·Phase: NA
-
Regulation of Endogenous Glucose Production by Central KATP Channels
NCT03540758 ·Status: RECRUITING ·Phase: PHASE2
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
NCT02669524 ·Status: COMPLETED ·Phase: NA
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
NCT01374594 ·Status: COMPLETED
-
Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge
NCT03061227 ·Status: COMPLETED ·Phase: NA
-
Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
NCT03227484 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
NCT05499702 ·Status: RECRUITING ·Phase: PHASE2
-
GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients.
NCT04105608 ·Status: COMPLETED ·Phase: NA
-
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
NCT02342834 ·Status: COMPLETED ·Phase: NA
-
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660 ·Status: COMPLETED ·Phase: NA
-
Studies of Insulin and Glucagon Action in the Liver
NCT07300982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
NCT00881543 ·Status: COMPLETED ·Phase: NA
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
NCT05098470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose
NCT01919788 ·Status: COMPLETED ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN